课题基金 / 基金详情

Genetic analysis of the ciliopathies ARPKD and Meckel syndrome

Genetic analysis of the ciliopathies ARPKD and Meckel syndrome
ARPKD 和梅克尔综合征纤毛病的遗传分析
批准号:
8393483
负责人:
Peter C. Harris
金额:
$29.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-15 至 2017-01-31

项目摘要

项目成果

Peter C. Harris的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In the last few years it has become clear that polycystic kidney diseases (PKDs) are ciliopathies, due to mutations in cilia related genes. In this proposal we will study two apparently recessively inherited PKDs, autosomal recessive PKD (ARPKD) and Meckel syndrome (MKS). In ARPKD, the disease is largely restricted to the kidney and liver, while MKS is a lethal, syndromic PKD in which central nervous system and digital defects are typically also found. ARPKD is considered a genetically homogenous disorder due to PKHD1 mutation, although studies of large populations with an ARPKD-like phenotype have found PKHD1 mutations in only about one half of individuals. MKS is genetically more complex with 11 genes identified and alleles at other loci also thought to play a role; possible oligogenic inheritance. Although on the surface these diseases appear very different, recent publications and our preliminary data suggest genetic overlap. Hypomorphic mutations in the autosomal dominant PKD (ADPKD) gene, PKD1, have been shown to cause an ARPKD-like disease and exon enrichment and NGS has shown PKHD1, and the related PKHDL1, alleles in MKS patients. The purpose of this study is to employ cutting-edge genetic methods to understand the full genetic load in these two disorders, while animal models will be utilized to determine the significance of detected variants, plus the strength of epistatic effects between ciliopathy genes. In the first aim a total of ~100 MKS and ~200 ARPKD-like families, that are genetically unresolved, will be analyzed by exon enrichment and next-generation sequencing of ciliopathy and other ciliogenes, plus, when appropriate, whole exome analysis. Variants will be assessed bioinformatically and in Aim 2 cellular systems and the model organisms C. elegans and zebrafish employed to assess the significance of the most promising variants. The concept that the phenotype found in MKS and some ARPKD-like families is due to alleles at more than one gene, that epistasis plays a central role, will be tested in Aim 3 employing C. elegans, zebrafish and interbreeding of mouse models of ciliopathies. The final aim will explore the role of the PKHD1 paralog and suspected ciliogene, PKHDL1, by developing knock- in/out mouse models to characterize expression and the phenotype associated with disruption of all transcripts. Together these studies will provide a much clearer view of the etiology of ARPKD-like disease and MKS and clarify the true complexity of these "simple" genetic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Facilitating personalized medicine of monogenic stone patients by genetic characterization
  • 批准号:
    10153916
  • 项目类别:
  • 资助金额:
    $19.88万
  • 财政年份:
    2020
  • 负责人:
    Peter C. Harris
  • 依托单位:
Identifying genetic modifiers of severity in ADPKD
  • 批准号:
    8335460
  • 项目类别:
  • 资助金额:
    $92.02万
  • 财政年份:
    2010
  • 负责人:
    Peter C. Harris
  • 依托单位:
Mutations detection and classification in ADPKD
  • 批准号:
    8076270
  • 项目类别:
  • 资助金额:
    $19.52万
  • 财政年份:
    2010
  • 负责人:
    Peter C. Harris
  • 依托单位:
Identifying genetic modifiers of severity in ADPKD
  • 批准号:
    8326913
  • 项目类别:
  • 资助金额:
    $14.0万
  • 财政年份:
    2010
  • 负责人:
    Peter C. Harris
  • 依托单位:
海外基金